Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 16, 2017
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
[ Thu, Mar 16th 2017
] - WOPRAI
Alethia Young Initiated (UTHR) at Sell on, Mar 16th, 2017
Alethia Young of Credit Suisse, Initiated "United Therapeutics Corporation" (UTHR) at Sell on, Mar 16th, 2017.
Alethia has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 0 agree with Alethia's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Alethia
- Eun Yang of "Jefferies" Downgraded from Hold to Sell and Held Target at $116 on, Monday, March 6th, 2017
- Hartaj Singh of "Oppenheimer" Initiated at Buy on, Wednesday, December 14th, 2016
- Geoff Meacham of "Barclays" Downgraded from Hold to Sell on, Tuesday, November 29th, 2016
